The longest ever randomised controlled trial of insulin glargine: study design and HbA(1c) findings

Diabetologia. 2009 Oct;52(10):2234-5; author reply 2236-9. doi: 10.1007/s00125-009-1477-6. Epub 2009 Aug 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetic Retinopathy / etiology*
  • Diabetic Retinopathy / metabolism
  • Glycated Hemoglobin A / metabolism*
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / adverse effects
  • Insulin / analogs & derivatives*
  • Insulin / therapeutic use
  • Insulin Glargine
  • Insulin, Long-Acting
  • Randomized Controlled Trials as Topic

Substances

  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • Insulin, Long-Acting
  • hemoglobin A1c protein, human
  • Insulin Glargine